花旗上调渤健目标价至180美元
Biogen(US:BIIB) Ge Long Hui·2026-01-09 08:41Group 1 - Citigroup raised the target price for Boehringer Ingelheim from $153 to $180 while maintaining a "Neutral" rating [1]
Biogen(US:BIIB) Ge Long Hui·2026-01-09 08:41Biogen(US:BIIB) Ge Long Hui·2026-01-09 08:41